Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

734 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Determinants of Influenza A infection rate in post-COVID-19 era.
Wagenhäuser I, Mees J, Reusch J, Lâm TT, Schubert-Unkmeir A, Krone LB, Frey A, Kurzai O, Frantz S, Dölken L, Liese J, Gabel A, Petri N, Krone M. Wagenhäuser I, et al. Among authors: frey a. J Infect. 2023 Oct;87(4):361-364. doi: 10.1016/j.jinf.2023.08.003. Epub 2023 Aug 9. J Infect. 2023. PMID: 37567511 Free article. No abstract available.
Immunogenicity and safety of coadministration of COVID-19 and influenza vaccination.
Wagenhäuser I, Reusch J, Gabel A, Höhn A, Lâm TT, Almanzar G, Prelog M, Krone LB, Frey A, Schubert-Unkmeir A, Dölken L, Frantz S, Kurzai O, Vogel U, Petri N, Krone M. Wagenhäuser I, et al. Among authors: frey a. Eur Respir J. 2023 Jan 6;61(1):2201390. doi: 10.1183/13993003.01390-2022. Print 2023 Jan. Eur Respir J. 2023. PMID: 36549716 Free PMC article.
Heterologous and homologous COVID-19 mRNA vaccination schemes for induction of basic immunity show similar immunogenicity regarding long-term spike-specific cellular immunity in healthcare workers.
Wagenhäuser I, Almanzar G, Förg FB, Stein A, Eiter I, Reusch J, Mees J, Herzog A, Vogel U, Frey A, Lâm TT, Schubert-Unkmeir A, Dölken L, Kurzai O, Frantz S, Gabel A, Petri N, Prelog M, Krone M. Wagenhäuser I, et al. Among authors: frey a. Vaccine. 2024 Aug 30;42(21):126132. doi: 10.1016/j.vaccine.2024.07.033. Epub 2024 Jul 20. Vaccine. 2024. PMID: 39034219 Free article.
Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS‑CoV‑2 infection: an analysis of the baseline examination of the German COVIDOM/NAPKON-POP cohort.
Shi Y, Strobl R, Apfelbacher C, Bahmer T, Geisler R, Heuschmann P, Horn A, Hoven H, Keil T, Krawczak M, Krist L, Lemhöfer C, Lieb W, Lorenz-Depiereux B, Mikolajczyk R, Montellano FA, Reese JP, Schreiber S, Skoetz N, Störk S, Vehreschild JJ, Witzenrath M, Grill E; NAPKON Study Group. Shi Y, et al. Infection. 2023 Dec;51(6):1679-1694. doi: 10.1007/s15010-023-02043-6. Epub 2023 May 25. Infection. 2023. PMID: 37231313 Free PMC article.
734 results